Europe Surgical Suture Market Growth Drivers and Forecast by 2027

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027

Europe Surgical Suture Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Absorbable and Non-Absorbable), Type (Monofilament, and Braided), Application (Cardiovascular Surgeries, Gynecological Surgeries, Ophthalmic Surgeries, Orthopedic Surgeries, General Surgeries, and Others), and Country

  • Report Date : Jun 2020
  • Report Code : TIPRE00011596
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 115
Page Updated: Mar 2021

The Europe surgical suture market is expected to reach US$ 1,413.74 million by 2027 from US$ 925.29 million in 2019. The market is estimated to grow at a CAGR of 5.6% from 2020 to 2027.



The growth of the market is attributed to the increasing number of orthopedic surgeries and cardiovascular surgeries, and government support for the healthcare industry. However, the adoption of robots in surgeries is likely to have a negative impact on market growth.

The Europe surgical suture market is expected to witness significant growth during the forecast period due to the rise in the number of cardiovascular surgeries and general surgeries across the globe. Thus, in Europe the conditions and symptoms such as rise in diabetic cases and lifestyle changes are leading to increasing number of cardiovascular surgeries and general surgeries. Since the last 25 years, the number of cardiovascular cases has increased in the European countries. As per the European Cardiovascular Disease Statistics in 2015, about 85 million people in Europe and 49 million in EU were suffering with cardiovascular diseases.

The UK is one of the key markets for surgical suture in Europe. As per the British Heart Foundation (BHF) statistics there are nearly 7 million people suffering from cardiovascular diseases in the UK, especially the aging population. Analyzing the facts for the cardiovascular disease, BHF conducted innovative health programs to improve services for people living with CVD or at risk of CVD.

Furthermore, the National Health Service (NHS) in England has a scheme that will help patients get benefited with the innovative products. For instance, an innovative and surgical suture that aims to reduce the risk of infection from Methicillin-resistant Staphylococcus aureus (MRSA), which causes serious skin infections or infect surgical wounds, will join the NHS schemes.

 

Europe Surgical Suture Market Segmentation


By Product

  • Absorbable Suture
  • Natural Sutures
  • Synthetic Sutures
  • Anti-microbial Sutures
  • Non-Absorbable Suture
  • Stainless Steel Sutures
  • Nylon Sutures
  • Prolene Sutures
  • Others

By Type

  • Monofilament
  • Braided

By Application

  • Cardiovascular Surgery
  • General Surgery
  • Gynaecology Surgery
  • Orthopaedic Surgery
  • Ophthalmic Surgery
  • Others

By Country

  • UK
  • Germany
  • France
  • Italy
  • Spain
  • The Netherlands
  • Belgium
  • Luxembourg

Company Profiles

  • Assut Medical Sarl
  • Péters Surgical
  • W. L. Gore and Associates
  • Medtronic (covidien)
  • Johnson and Johnson medical n.V. (Ethicon)
  • B. Braun Melsungen Ag
  • Smith and Nephew
  • serag-Wiessner Gmbh and Co. Kg
  • Teleflex Incorporated
  • Demetech Corporation

Europe Surgical Suture Report Scope

Report Attribute Details
Market size in 2019 US$ 925.29 Million
Market Size by 2027 US$ 1,413.74 Million
Global CAGR (2020 - 2027) 5.6%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Product
  • Absorbable and Non-Absorbable
By Type
  • Monofilament
  • Braided
By Application
  • Cardiovascular Surgeries
  • Gynecological Surgeries
  • Ophthalmic Surgeries
  • Orthopedic Surgeries
  • General Surgeries
Regions and Countries Covered Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Market leaders and key company profiles
  • Assut Medical Sarl
  • P
  • Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Identifying Emerging Markets
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Boosting Operational Efficiency
    • Strategic Planning
    • Investment Justification
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Our Clients
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo